INTRODUCTION
Twenty-five years ago a patient with complete ~ailur~ of heart, lungs, kidneys, or gastromtestmal tract, died on a time scale which varied from a few minutes to many weeks or months, depending on the function of the particular organ. Today, patients with multisystem failure can be kept alive by means of artificial supports for failing organs.
DEVELOPMENT OF LIFE SUPPORT
Until the late 1940's, failure of vital organs could be managed by conservative medical means only. Over the following 20 years, much effort was put into developing methods of preventing death in patients considered "too well to die ".
Cardiopulmonary resuscitation in the modern setting dates from 1874, when Schiff, professor of Physiology in Florence, outlined the procedure for internal cardiac massage in cats (Keen 1904) . In 1901, Igelsrud performed successful internal cardiac massage in a woman who had collapsed during chloroform anaesthesia (Keen 1904) . The first successful cardiac massage in England was carried out by Arbuthnot Lane of Guys Hospi.tal at the suggestion of Ernest Starling (Starlmg and Lane 1902) . External cardiac massage, although practiced before 1900, did not become popular until 1960, when its effectiveness in maintaining an adequate cardiac out-put was shown by Kouwenhoven and his colleagues (Kouwenhoven, Jude and Knickerbocker 1960) . Beck successfully applied internal defibrillation to the human heart in 1947 (Beck, Pritchard and Feil 1947) and Zoll used external defibrillation, as practiced today, in 1956 (Zoll et al. 1956) . It is little appreciated that modern cardiopulmonary resuscitation techniques originated from an appeal to the Rockefeller Institute by the Consolidated Edison Company of New Yark City, for help in reducing the high rate of electric fatalities in the Company's line-men in in 1926 (Kouwenhoven and Langworthy 1973) .
. Artificial ventilation o.f the lungs has a long hIstory. Hunter had mvented a bellows in 1776 for the Royal Humane Society for the purpose of resuscitating the drowned. His observations on the use of artificial breathing and its effect on the exposed dog heart make fascinating reading (Hunter 1776) . However, it was not until 1958 that Safar popularised mouth-to-mouth resuscitation (Safar 1958) . He subsequently pioneered teaching and organization of cardiopulmonary resuscitation and emphasized the importance of integration of external cardiac massage and artificial ventilation, with appropriate timing (Safar et al. 1974) . Artificial ventilation in anaesthesia dates from 1932 when Gale and Waters used it to prevent pulmonary collapse during thoracic operations (Gale and Waters 1932) . Guedel and Treweek, in 1934 , employed controlled respiration during ether anaesthesia (Guedel and Treweek ] 934), and Crafoord introduced the first anaesthesia ventilator in 1940 (Anderson, Crafoord and Frenckner 1940 ). Nosworthy's classic paper on artificial ventilation appeared in 1941 (Nosworthy 1941) . Curare was introduced into clinical anaesthesia in 1942 (Griffith and Johnson 1942) , its use being reviewed by Gray (Gray and Halton 1946) . It was not until 1953 that Lassen reported the prolonged use of Intermittent Positive Pressure Respiration in the management of patients with respiratory failure due to poliomyelitis (Lassen 1953) . A patient with severe tetanus managed using muscle paralysis and ventilation, was reported in 1956 (Crampton-Smith, Hill and Hopson 1956) . The Ambu bag, one of the early hand-held resuscitators, was introduced in 1957 (Ruben and Ruben 1957) .
Cardiac pacing in patients with complete heart block was introduced by the extrathoracic route in 1952 (Zo1l1952) by myocardial implantation in 1957 (Weirich, Gott and Lillehei 1957) and by the transvenous endocardial route in 1959 (Furman and SchwedeI1959) .
The first successful oxygenator to enable cardiac surgery to be performed on the arrested heart was devised between 1937 and 1953 (Miller, Gibbon and Fineberg 1953 )-a screen oxygenator. This was followed by the disc oxygenator in 1948 (Melrose 1953 , Bjork 1948 , the bubble oxygenator (DeWall et al. 1957 ) and the membrane oxygenator in 1960. This latter was subsequently developed by Bramson (Bramson et al. 1965) . Aortic balloon counter pulsation, now used in the treatment of cardiogenic shock was developed between 1953 and 1967 (Kantrowitz et al. 1968) .
The earliest experilllents in peritol/cal dialysis date back to the 1870's, but it was Ganter in 1923 who carried out the first peritoneal dialysis in man (Ganter 1923) . Many names are associated with development of this technique for treatment of renal failure, and the procedure was well established by the 1950's. Kolff published his book, "New \Vays of Treating Uraemia ", in 1947 (Kolff 1947 , and by the late 1940's, haemodialysis was established as a safe method of treating renal failure.
Intravenous feeding has evolved from administration of dextrose in the late 1800's, to the introduction of intravenous fats in 1920 (Yamakawa 1920 ), and amino acids in 1937 (Elm an 1937 . Although many workers were involved in improvements, and as far back as 1944 there were reports of complete parenteral feeding, it was Dudrick in America (Dudrick 1968) and Wretlind in Sweden (Wretlind 1972) , who stimulated the wide-spread use of parenteral feeding during the 1960's.
In the field of hepatic failure, Williams (1975) has commented on attempts to develop satisfactory artificial liver supports. These have included perfusion through an isolated pig's, baboon's or human cadaver's liver, and haemoperfusion through charcoal columns. This is still an experimental field.
LIFE SUPPORT IN INTENSIVE CARE
As new equipment and people with expertise in its use became available, it became clear that life support was best carried out in special areas. This meant, initially, the recovery room, then separate general intensive care areas, followed by special intensive care areas such as coronary care, respiratory care, dialysis, burns, neonatal units, etc. Such areas treated few patients, and concentrated the complex equipment and highly trained staff to utilise this equipment in specially designed areas. While a few post-operative observation rooms were in use as far back as the early 1940's, it was not until the late 1950's that intensive care areas began to develop. In Australia, developments in intensive care and life support did not lag behind the rest of the world (Hercus 1962 ).
Today, it is possible to rapidly institute multi-system life support in the critically ill patient. The use of life support facilities enables a patient to be kept alive long past the time at which he would have previously died. In the longer term management of specific problems, pacemakers may be implanted, parental feeding continued at home, and renal transplant carried out. Attempts at heart, lung and liver transplant have been made, and research into devices to permanently take over the functions of these organs is progressing (Kolff and Lawson 1975) .
All of these efforts are directed at maintaining normal brain function, since irreversible damage to this organ cannot be treated. However, considerable interest has been generated by reports such as that of Trubuhovich and Spence (1974) , who achieved a 58% good recovery in young patients treated by prolonged sedation, paralysis and ventilation for acute cerebral oedema, the largest group following trauma.
Monitoring has played an important role during the use of life support systems, and in facilitating effective timing for initiation of such support. A detailed discussion of this area has recently been provided (Laver 1976) .
The whole question of the cost of such facilities and the philosophy behind their usage, has been challenged by a number of people. I van Illich, in his book, " The Medical Nemesis ", makes statements like the following:
"Intensive cardiac care units are other gadgets which have high visibility and no proven advantage for the care of the sick". Again :
"All inspiring medical technology has combined with egalitarian rhetoric to create the dangerous delusion that contemporary medicine is highly effective". (Illich 1975) . In order to clarify the philosophical and medical issues involved in life support, the following approach has been found useful. Death can be regarded not as a single event, but as a process which can be interrupted in many patients by advances in technology. For example, a person eating in a restaurant chokes on a piece of meat. He can no longer breathe, no oxygen enters the blood, his brain begins to stop functioning. If the meat is removed, breathing resumes and he recovers. If the meat is not removed, his heart eventually stops from lack of oxygen. If the meat is then removed and he is given mouth-to-mouth breathing, external cardiac massage, is transported rapidly to hospital and his heart shocked back to normal rhythm, he may recover completely. If no treatment is begun, he dies. But the important thing is that the process of dying began when he first choked on the meat. Life support systems can be regarded as technological aids to interrupting the death process in a patient who may have a reversible illness. There is no doubt that intensive care life support facilities have saved many useful lives.
ETHICAL PROBLEMS AND INTENSIVE CARE
Let us now look at some of the ethical statements that have been made by the medical profession on the question of life and death, particularly in relation to the use of life support systems. The original ethical statement was the Hippocratic Oath which, in part, stated: "I will follow that system of regimen which, according to my ability and judgement, I consider for the benefit of my patients and abstain from whatever is deleterious and mischievous. I will give no deadly medicine to anyone if asked, nor suggest any such counsel ". In 1968, as a result of the developments in life support systems and the advent of successful organ transplantation, the World Medical Association met and published the Declaration of Sydney: "The determination of the time of death is in most countries the legal responsibility of the physician and should remain so. Usually he will be able without special assistance, to decide that a person is dead, employing the classical criteria known to all physicians. Two modern practices in medicine, however, have made it necessary to study the question of the time of death further:
1. The ability to maintain by artificial means the circulation of oxygenated blood through tissues of the body which may have been irreversibly injured and 2. The use of cadaver organs, such as heart or kidneys for transplantation.
" A complication is that death is a gradual process at the cellular level with tissues varying in their ability to withstand deprivation of oxygen. But clinical interest lies not in the state of preservation of isolated cells but in the fate of the person. Here the point of death of the different cells and organs is not so important as the certainty that the process has become irreversible by whatever techniques of resuscitation that may be employed. This determination will be based on clinical judgement supplemented if necessary by a number of diagnostic aids of which the electroencephalograph is currently the most helpful. However, no single technological criterion is entirely satisfactory in the present state of medicine nor can anyone technological procedure be substituted for the overall judgement of the physician. Determination of the point of death of the person makes it ethically permissible to cease attempts at resuscitation and in countries where the law permits, to remove organs from the cadaver provided that prevailing legal requirements of consent have been fulfilled" (Declaration of Sydney 1973). The New York Academy of Medicine, in 1971, stated: "When, in the opinion of the attending physicians, measures to prolong life which have no realistic hope of effecting significant improvement will cause further pain and suffering to the patient and the family, we support conservative, passive medical care in place of heroic measures in the management of a patient afflicted with a terminal illness" (Committee on Medicine 1973). The American Heart Association, in 1974, in a statement on standards for cardiopulmonary resuscitation, went further than this when they said: "Cardiopulmonary resuscitation is not indicated in certain situations, such as in cases of terminal irreversible illness where death is not unexpected or where prolonged cardiac arrest dictates the futility of resuscitation efforts. Resuscitation in these circumstances may represent a positive violation of an individual's right to die with dignity" (American Heart Association 1974).
Not only is employment of life support philosophically and morally wrong in certain situations, it is also costly, both financially and emotionally.
COSTS AND BENEFITS OF INTENSIVE CARE
In an Australian pilot study carried out in 1975, the average cost of an intensive care bed was found to be $168 per day, with a range from $80 to $233 per day, depending on the type of patient, compared with a standard ward cost of $54 per day. In this study, staff salaries accounted for 50% of the cost, investigations, 32%, drugs and fluids, 12%, disposable items, 6%. (Phillips and Ryan 1975) . A second study revealed a cost of $275 per day, in a Unit with a much higher staff/patient ratio, both medical and nursing (Gilligan et al. 1976) . For many reasons these costs were less than reported in overseas studies-$961.62 per day for patients treated for acute renal failure following ruptured abdominal aortic aneurysm (Morgan et al. 1973) , and $761 per day for patients treated in a general surgical intensive care unit (Civetta 1973) .
Costing methods have varied in different studies. It is easy to calculate salaries, cost of investigations, drugs, infusion solutions and disposables, but more difficult to include such factors as depreciation of equipment. Cullen et al. (1976) have recently reported a study involving 226 critically ill patients, and quoted an average hospitalization cost of $14,304 per patient. In special areas such as coronary care units with lower staff-to-patient ratios and less investigations, drugs and fluids than in general intensive care, Bloom and Peterson (1973) reported a mean cost of $119 per day. Reynell and Reynell (1972) calculated S£540 per life saved in a coronary care unit.
Benefits have been looked at in different ways. Morgan et al. (1973) reported one survivor out of 18 patients treated for acute renal failure following aneurysm surgery. The average stay in the unit was 17 days. In Cullen's group of 226, 54% had died at one month, and 73% at 12 months, and of the 62 survivors at 12 months, only 26 were back to their pre-illness condition.
It should, however, be noted that a further 1797 patients, not as critically ill as the 226 studied, passed through the unit during the period studied. The one year mortality in this group was 0% of a sub-group of 364, 15% of a sub-group of 771, and 21 % of a sub-group of 662 (Cullen et al. 1976 ).
In a study conducted at the Hospital of the University of Pennsylvania in Philadelphia, it was found that the mortality of patients treated with mechanical ventilation for more than 12 hours before the introduction of a special respiratory care unit was 63%. After the establishment of the unit, the mortality in the same group fell to 36 % (Rogers, \Veiler and RuppenthaI1972) . Longmore and Rehahn (1975) compared the estimated cost of treatment of patients with nephritis and nephrosis, including dialysis and renal transplantation, with the loss of income if there was no treatment, and tried to estimate the cost to the communitv of the deaths of men of working age from ischaemic heart disease. While this latter study was not related to coronary care, their implications were that expensive methods of treatment could be justified in the treatment of younger people with such diseases.
Another cost, the cost to the relatives of patients treated in intensive care, both dollar and social/emotional costs, was examined by :\Iorgan et al. (J973). He was surprised to find little evidence of financial hardship or of emotional problems among relatives or survivors. Griner (1973) stressed the need for assessment of the cost/benefit ratio for intensive care units. He suggested that the benefits of such units were difficult to assess, but included not only survival of some patients who would otherwise have died, but also improvement in the general standard of care of acute illness in the hospital and improved doctor and nurse education. Benefits occurring from sophisticated monitoring allow precise documentation of the effects of treatment regimes for acute care. Morgan et al. (1973) considered that expenditure of the order required by intensive care " in treatment of illness with a low probability of survival may be justifiable when that illness is a rare event". Cullen et al. (1976) considered that cost control could be achieved "by not accepting patients for whom intensive care is inappropriate; and by discontinuing intensive care in patients whose survival to a successful outcome is highly unlikely". They believed that once a patient was accepted for intensive care, cost should not be a consideration.
RATIONAL USE OF LIFE SUPPORT IN INTENSIVE CARE
If it is accepted that intensive care is expensive, but that there are definite benefits, it remains to rationalise the use of such facilities by such steps as the following:
(a) To establish criteria for acceptance of patients into intensive care units. For these aims to be achieved, there is a case to be made for regionalisation of intensive care facilities. It has been said that every acute general hospital with more than 100 beds should have an intensive care unit (Galbally 1972 ) but clearly it is not feasible to staff every such unit with 24 hour senior medical staff, registrar and resident, medical officer cover, and a 24 hour 1-to-1 nurse/patient ratio. One solution would be to have different types of general intensive care units in different hospitals as has been done in Sweden (Spri 1973) and to manage patients with multi-system failure in the intensive care units of major hospitals. This is already being done in neo-natal intensive care. Major centres with adequate staffing can readily mount a retrieval service to evaluate, resuscitate and bring such patients back safely to the most appropriate unit in the centre, using mobile intensive care facilities. These may range from specially constructed mobile units operating from a single location in the city (J ames and Coombs 1976) to less elaborate vehicles of adequate size based in key ambulance stations around a city (McCleave 1976) . Transport by air ambulance and by helicopter will be utilised more in the future. CONCLUSION I t has been indicated that modern medical knowledge and technology have, over the last 25 years especially, enabled the physician to artificially support the function of essential organs. It is now possible to postpone death in many patients and future advances in this technology will undoubtedly be made. On the other hand, death is an inevitable end to life, and must be accepted when it is due. We must therefore address ourselves to the problem of finding ways of foreseeing who will benefit in a real way from organ support, and who will suffer. Given the advances made, and the resources available, we must be prepared to " pull out all stops", as it were, for the patient who can be returned to a full and useful life if recovered from a potentially fatal illness. But we must not be guilty of prolonging death in a patient whose time has come.
The above concepts are amplified by quotations from two sources, far apart in time, but close in concept. Allan Bums, Lecturer in Surgery and Anatomy at Glasgow University, wrote in 1809-"Where, however, the cessation of vital action is very complete, we ought to inflate the lungs and pass electric shocks through the chest. Practitioners ought never, if death has been sudden and the person not very advanced in life, to despair of success till he has unequivocal signs of real death". (Bums 1809). John Talbot, in his introduction to Jude and Elam's book in 1965, wrote-" Resuscitation of the dying patient with irreparable damage to the heart, lungs, brain, or any other vital system of the body has no medical, ethical, or moral justification". (Talbot 1965) . ACKNOWLEDGEMENT I would like to thank Mrs. Marioll Wallace for her assistance in the preparation of the manuscript.
